Events

Dr. Forster will describe the motivations for change in healthcare and describe how the Ottawa Hospital is supporting transformation using three related concepts: learning systems, data democratization, and open innovation.  At the foundation of these concepts is a need for strong leadership and trust to support the meaningful collaborations required to achieve meaningful impacts.

The Web-Accessible Population Pharmacokinetic Service – Hemophilia (WAPPS-Hemo) is a clinical decision support tool aimed at using pharmacokinetics of prophylactic clotting factor replacement therapy as a means for individu

Abstract

The basic principles and experimental set-ups for Edge Illumination and Beam Tracking X-ray phase-contrast imaging (XPCI) are introduced, along with examples on key applications where phase-based imaging complements and advances the more conventional attenuation-based X-ray imaging. X-ray dark-field techniques are also discussed with an emphasis on the most recent developments on tomography and directional imaging.

The Centre for Bioengineering and Biotechnology (CBB) is proud to announce that registration for the forthcoming conference “Waterloo for Health, Technology and Society

The Centre for Bioengineering and Biotechnology (CBB) is proud to announce that registration for the forthcoming conference “Waterloo for Health, Technology and Society

Profs Present: Wearable sensors to inform mobility and health: Novel applications and advances in methodology

Abstract

DNA aptamers are single-stranded DNA oligonucleotides that can selectively bind to target molecules. They can be used for the detection of various metabolites and proteins as disease biomarkers. Our lab recently discovered new aptamers that can bind to caffeine, uric acid and lactate, and converted them to highly sensitive and selective fluorescent biosensors. In addition, we have isolated aptamers that can bind to exosomes, which could be used for the isolation and detection of exosomes as important disease biomarkers. Finally, we have isolated aptamers that can bind to pig cornea and established an aptamer-enhanced ocular drug delivery method to treat dry eye diseases.

The Centre for Bioengineering and Biotechnology (CBB) and the Health Initiative Office will be co-hosting partners from the University of Twente from October 2-4, 2023. The University of Waterloo has an active institutional-level agreement (signed in July 2022) with the University of Twente, located in the Netherlands.

Abstract

This talk will introduce micro-and nanorobots and their potential to revolutionize medicine. One of the main goals of microrobots is to make medical interventions more targeted and less invasive. Nano-and microrobots show great potential for active and remote-controlled motion inside the human body. Possible future applications include active, targeted delivery of therapeutics to diseased sites (e.g. tumours), cell delivery for regenerative therapy and non-invasive surgery. The removal of obstructions inside the body such as blood clots, renal stones or other blockages in a minimal invasive manner is another main subject of our research. This talk will give an overview of the very interdisciplinary research that combines expertise from robotics, medicine, engineering, chemistry and biology.

Abstract

This session covers the basics of Intellectual Property (IP) protection with a focus on patents.

You’ll learn about the different types of IP protection available and some of the most common pitfalls to avoid. Learn about the resources available to you at the University of Waterloo, including the Waterloo Commercialization Office (WatCo). Hear how IP is used to commercialize technology through licensing or start-up creation. Included is a brief discussion on “Are You an Inventor?", this highlights some key points for consideration as this issue has come up when there may be a misunderstanding between Faculty and Grad Students.” Also included are some helpful tips for those interested in creating a Start-Up.